RecruitingNot Applicable

Ultrasound-Guided Transversus Abdominis Plane Block Versus Epidural Block for Umbilical Hernia Analgesia

Turkey (Türkiye)30 participantsStarted 2026-01-15

Plain-language summary

This observational study aims to compare the postoperative analgesic effectiveness of ultrasound-guided transversus abdominis plane (TAP) block and single-dose epidural anesthesia in patients undergoing umbilical hernia surgery. Pain intensity will be assessed using the Visual Analog Scale (VAS) at predefined postoperative time points. The study seeks to determine which analgesic approach provides superior pain control and patient satisfaction in the postoperative period.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 to 65 years * Patients scheduled for elective umbilical hernia surgery * ASA physical status I or II * Patients who undergo surgery under either: Single-dose epidural anesthesia, or general anesthesia with postoperative ultrasound-guided transversus abdominis plane (TAP) block, as part of routine clinical practice * Ability to understand and use the Visual Analog Scale (VAS) * Provision of written informed consent Exclusion Criteria: * ASA physical status III or higher * Known allergy or contraindication to local anesthetic agents * Coagulopathy or ongoing anticoagulant/antiplatelet therapy contraindicating regional anesthesia * Infection at the site of epidural or TAP block application * History of chronic pain, long-term opioid use, or chronic analgesic consumption * Neurological disorders affecting pain perception or assessment * Severe hepatic or renal disease * Pregnancy or lactation * Inability to cooperate with postoperative pain assessment or inability to use VAS * Emergency surgery

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visuel Analog Scale 6th hour

Timeframe: postoperative 6th hour

Trial details

NCT IDNCT07327463

SponsorSakarya University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-09

View on ClinicalTrials.gov More Umbilical Hernia trials